ECR GLOBAL
Live / Registered — Registered (as of 03 Sept 2024)
What this means for you
Registered since 03 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97632470
- Registration number
- 7496633
- Mark type
- Design + words
- Filed
- 14 Oct 2022
- Published for opposition
- 17 Oct 2023
- Registered
- 03 Sept 2024
- Attorney of record
- Nazly Aileen Bayramoglu
Goods and services
- Class 042 — Scientific and technological services: Technological research in the field of healthcare; research and development of new products for others in the medical and pharmaceutical industries; scientific research in the nature of conducting clinical trials for others; medical research; Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing information about medical research; Medical research services
Owner
- Elixir Clinical Research Co.,Ltd., Shanghai, CN
- Elixir Clinical Research Co.,Ltd., Shanghai, CN
- Elixir Clinical Research Co.,Ltd., Shanghai, CN
Prosecution history
- 03 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 29 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 20 May 2024 — USE AMENDMENT FILED
- 26 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 12 Dec 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Oct 2023 — PUBLISHED FOR OPPOSITION
- 27 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE